Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research progress on application of single-cell TCR/BCR sequencing technology to the tumor immune microenvironment, autoimmune diseases, and infectious diseases. | Front Immunol | 2022 | 36059506 | PubTator, text mining | PubMed |
| Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer. | BMC Med Genomics | 2022 | 36056349 | PubTator, text mining | PubMed |
| Identification of PLAUR-related ceRNA and immune prognostic signature for kidney renal clear cell carcinoma. | Front Oncol | 2022 | 36052236 | PubTator, text mining | PubMed |
| Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma. | Front Genet | 2022 | 36051690 | PubTator, text mining | PubMed |
| OXTRHigh stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling. | Nat Commun | 2022 | 36045118 | PubTator, text mining | PubMed |
| Microbiota and COVID-19: Long-term and complex influencing factors. | Front Microbiol | 2022 | 36033885 | PubTator, text mining | PubMed |
| Biomarkers of Inflammation Increase with Tau and Neurodegeneration but not with Amyloid-β in a Heterogenous Clinical Cohort. | J Alzheimers Dis | 2022 | 36031900 | PubTator, text mining | PubMed |
| Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges. | Int J Mol Sci | 2022 | 36012170 | PubTator, text mining | PubMed |
| Transcriptional Response of Blood Mononuclear Cells from Patients with Inflammatory and Autoimmune Disorders Exposed to "Krakow Smog". | Cells | 2022 | 36010662 | PubTator, text mining | PubMed |
| Fcγ receptor-mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies. | JCI Insight | 2022 | 35998045 | PubTator, text mining | PubMed |
| Comprehensive analysis of the endoplasmic reticulum stress-related long non-coding RNA in bladder cancer. | Front Oncol | 2022 | 35992824 | PubTator, text mining | PubMed |
| Characterizing the role of SLC3A2 in the molecular landscape and immune microenvironment across human tumors. | Front Mol Biosci | 2022 | 35992269 | PubTator, text mining | PubMed |
| A LIGHT-HVEM/LTβR axis contributes to the fibrosis of intrauterine adhesion. | J Reprod Immunol | 2022 | 35987137 | PubTator, text mining | PubMed |
| Increased proportion of follicular helper T cells is associated with B cell activation and disease severity in IgA nephropathy. | Front Immunol | 2022 | 35983053 | PubTator, text mining | PubMed |
| Serological biomarkers in autoimmune GFAP astrocytopathy. | Front Immunol | 2022 | 35983033 | PubTator, text mining | PubMed |
| Rethinking the initial changes in subarachnoid haemorrhage: Focusing on real-time metabolism during early brain injury. | EBioMedicine | 2022 | 35973388 | PubTator, text mining | PubMed |
| Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa. | Front Immunol | 2022 | 35967369 | PubTator, text mining | PubMed |
| Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy. | Front Immunol | 2022 | 35967338 | PubTator, text mining | PubMed |
| Necroptosis-associated long noncoding RNAs can predict prognosis and differentiate between cold and hot tumors in ovarian cancer. | Front Oncol | 2022 | 35965557 | PubTator, text mining | PubMed |
| Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine. | Invest New Drugs | 2022 | 35962880 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=31